SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001104659-20-027249
Filing Date
2020-02-28
Accepted
2020-02-28 17:15:54
Documents
7

Document Format Files

Seq Description Document Type Size
1 425 a20-11297_1425.htm 425 18042
2 GRAPHIC g112971bci001.gif GRAPHIC 77769
3 GRAPHIC g112971bci002.gif GRAPHIC 67505
4 GRAPHIC g112971bci003.gif GRAPHIC 60088
5 GRAPHIC g112971bci004.gif GRAPHIC 60531
6 GRAPHIC g112971bci005.gif GRAPHIC 68434
7 GRAPHIC g112971bci006.jpg GRAPHIC 98335
  Complete submission text file 0001104659-20-027249.txt   616311
Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Filed by) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 425
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences

Mailing Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704
Business Address 2 HOLZMAN ST. WEIZMANN SCIENCE PARK REHOVOT L3 76704 97289316233
Foamix Pharmaceuticals Ltd. (Subject) CIK: 0001606645 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-36621 | Film No.: 20672213
SIC: 2833 Medicinal Chemicals & Botanical Products
Office of Life Sciences